Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Kovsies in top four in Global Business Challenge
2015-05-06

Photo: Mark Steenbok (Bloemfontein Courant) 

 

Christiaan Paulsen (team leader), Sias Conradie, Jannie de Wet and Frikkie Jacobs.

Four Kovsies in the Department of Mathematical Statistics and Actuarial Sciences are one of the top four teams in the Chartered Institute of Management Accountants’ (CIMA) Global Business Challenge. 178 teams registered to participate in the competition.

 

Team Bernoulli from the UFS will compete against two teams: one from the University of Pretoria and one from the Chartered Accountant Training Institute in Sandton. The winning team will win a trip to Poland, Europe to represent their university and country at the 2015 global final.

 

This international business competition is for undergraduates around the world, designed to bring out the best in the young business leaders of tomorrow.

 

Team leader, Christiaan Paulsen, said: “We are overjoyed to be in the final. However, our true success is in what we learned along the way”.

 

The team has to present a business case study, showcasing their talent in business management. During this competition, the team has

  • learned to analyse and solve a real-life business case study;
  • -obtained first-hand experience of the skills required to be a business leader;
  • enhanced their team building skills; and 
  • developed their presentation skills.  

Students from Australia, Bangladesh, China, Ghana, Hong Kong SAR, India, Indonesia, Ireland, GCC, Malaysia, Myanmar, Nepal, New Zealand, Nigeria, Pakistan, Phillipines, Poland, Russia, Singapore, South Africa, Sri Lanka, Thailand, Ukraine, United Kingdom, Vietnam, and Zambia are taking part in the competition.

 

This competition is organised by CIMA in conjunction with Barclays.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept